Abstract

Antigen presentation by MHC I molecules requires the generation of peptides in the cytosol, ferrying of peptides from cytosol to endoplasmic reticulum, loading of MHC I with peptides, and transport of MHC I‐peptide complexes to the cell surface. Hsp90 is a cytosolic chaperone known to associate with peptide and peptide precursors of MHC I epitopes. We report here that treatment of a variety of cells with hsp90 inhibitors leads to generation of “empty” MHC I molecules on the cell surface, due to inhibited loading of MHC I with peptides. Inhibition of hsp90 does not inhibit protein synthesis in general, nor synthesis of MHC I in particular, nor does it affect the activity of proteasomes. Hsp90‐inhibited cells, like lactacystin‐treated cells, are poor stimulators of T lymphocytes. The role of hsp90 in presentation of an ovalbumin epitope is shown to be at a post‐proteasomal step: hsp90 associates with N‐terminally extended precursors of the SIINFEKL epitope, and such peptides are depleted from hsp90 preparations in inhibitor‐treated cells. These results argue for a substantial role for hsp90 in chaperoning of antigenic peptides in direct presentation.This work was supported by NIH grant CA 084479 to P.K.S.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.